An inhibitor of COMT and tyrosine hydroxylase
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

U-0521

Item No. 36314

Technical Information
Formal Name
1-(3,4-dihydroxyphenyl)-2-methyl-1-propanone
CAS Number
5466-89-7
Synonyms
  • 3′,4′-Dihydroxy-2-methylpropiophenone
  • NSC 27389
Molecular Formula
C10H12O3
Formula Weight
Purity
≥95%
Formulation
A solid
DMF: 3 mg/mlDMSO: 5 mg/ml
λmax
231, 277, 308 nm
SMILES
O=C(C(C)C)C1=CC=C(C(O)=C1)O
InChi Code
InChI=1S/C10H12O3/c1-6(2)10(13)7-3-4-8(11)9(12)5-7/h3-6,11-12H,1-2H3
InChi Key
VDQLKIBLTMPAHI-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    U-0521 is an inhibitor of catechol-O-methyltransferase (COMT; Ki = 7.8 µM for the rat liver enzyme) and tyrosine hydroxylase (IC50 = 1 µM for the rabbit adrenal enzyme).1,2 It enhances epinephrine-induced contractions of isolated rabbit atria when used at a concentration of 55 µM.1 U-0521 (41.5 µmol/kg) also enhances isoprenaline- or epinephrine-induced increases in blood glucose levels in pancreatectomized rats.3 It decreases blood pressure in spontaneously hypertensive, but not normotensive, rats when administered at a dose of 50 mg/kg.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Giles, R.E., and Miller, J.W. A comparison of certain properties of catechol-O-methyl transferase to those of adrenergic beta receptors. J. Pharmacol. Exp. Ther. 156(2), 201-206 (1967).

    2. Lloyd, T., Boyd, B., Walega, M.A., et alA comparison of 2-hydroxyestradiol and U-0521 (3'4'-dihydroxy-2-methylpropiophenone, Upjohn) as in situ and in vitro inhibitors of tyrosine hydroxylase. J. Neurochem. 38(4), 948-954 (1982).

    3. Proença, J., and Guimarães, S. Influence of inhibition of extraneuronal uptake and of O-methylation on the hyperglycaemia caused by sympathomimetic amines in depancreatized rats. J. Pharm. Pharmacol. 44(2), 139-141 (1992).

    4. Lloyd, T., and Waldman, C.D. The antihypertensive effect of U-0521 (3',4'-dihydroxy-2-methylpropiophenone). Life Sci. 31(19), 2121-2127 (1982).